Microbial Escape Mechanisms
1.
Failure of Host defense mechanisms
a.
In the normal course of an infection, disease is followed by an adaptive
immune response that clears the infection and establishes a state of protective
immunity.
b.
However, there are circumstances in which there are failures of host
defense against infection:
i.
avoidance or subversion of a normal immune response by the pathogen.
ii.
inherited failures of defense because of gene defects.
iii.
acquired immune deficiency syndromes, a generalized susceptibility to
infection which is itself due to the failure of the host to control and destroy
HIV.
c.
The propagation of a pathogen depends on its ability to replicate in a
host and to spread to new hosts.
d.
Common pathogens must therefore grow without activating too vigorous an
immune response, and conversely, must not kill the host too quickly.
e.
The most successful pathogens persist either because they do not elicit
an immune response, or by evading the response once it has occurred.
2.
Antigenic Variation
a.
One way in which an infectious agent can evade immune surveillance is by
altering its antigens.
b.
This is particularly important for extracellular pathogens, against which
the principal defense is production of antibody to their surface structures.
c.
Wide variety of Antigenic types:
i.
many infectious agents exist in a wide variety of antigenic types.
ii.
for example, there are 84 known types of Streptococcus pneumoniae,
an important cause of bacterial pneumonia.
iii.
each type differs from the others in the structure of its polysaccharide
capsule.
iv.
the different types are distinguished by serological tests and are known
as serotypes.
v.
infection with one serotype of such an organism can lead to type-specific
immunity, which protects against re-infection with that type but not with a
different serotype.
vi.
the result is that essentially the same pathogen can cause disease many
times in the same individual.
d.
Antigenic drift: point mutations in the genes encoding the surface
antigens such that individuals previously infected with old variant are now
susceptible to the new strain
as
antibodies cannot recognize the mutant antigen.
e.
Antigenic shift: reassortment of the virus and related viruses in an
animal host, leading to major changes in the viral surface antigen.
3.
Latency of some viral infections
a.
Viruses betray their presence to the immune system once they have entered
cells by directing the synthesis of viral proteins, fragments of which are
displayed on the surface MHC molecules of the infected cells.
b.
To replicate, a virus must make viral proteins, and rapidly replicating
viruses which produce acute viral illnesses, are therefore readily detected by T
cells.
c.
Some viruses enter a state of latency in which the virus is not
transcriptionally active.
d.
In the latent state, the virus does not cause disease, but, because there
are no viral peptides to flag its presence, it cannot be eliminated.
e.
Such latent infections can later be reactivated and this results in
recurrent illness.
f.
Herpes simplex viruses persist in a latent state in the sensory neurons
until factors such as sunlight, bacterial infection and immune suppression
reactivates it.
g.
There are two reasons why the sensory neuron remains infected:
i.
the virus is quiescent in the nerve and therefore few viral proteins are
produced, generating few virus-derived peptides to present on MHC class I.
ii.
neurons carry very low levels of MHC class I molecules, which makes it
harder for CD8 T cells to recognize infected cells and attack them.
h.
Acute infection of B lymphocytes by Epstein-Barr virus:
i.
EBV infects B cells, causing them to proliferate and produce virus.
ii.
this leads to proliferation of antigen-specific T cells which kill the
infected B cells.
iii.
however, a fraction of B cells become latently infected.
iv.
these cells express a viral protein, EBNA-1, which is needed to maintain
the viral genome, but interacts with the proteasome to prevent its own
degradation into peptides that would elicit a T-cell response.
4.
Resistance of Defense mechanisms
a.
Some pathogens induce a normal immune response but have evolved
specialized mechanisms for resisting its effects.
b.
For instance, some bacteria that are engulfed in the normal way by
macrophages have evolved ways of avoiding destruction by these phagocytes;
indeed they use macrophages as their primary host.
c.
Mycobacterium tuberculosis, for example, is taken up by
macrophages, but prevents the fusion of the phagosome with the lysosome,
protecting itself from the bactericidal actions of the lysosomal contents.
d.
Other microorganisms, such as Listeria monocytogenes, escape from
the phagosome into the cytoplasm of the macrophage, where they can multiply
readily, and then spread to adjacent cells in tissues.
e.
The protozoan parasite Toxoplasma gondii can generate its own
vesicle, which isolates it from the rest of the cell because it does not fuse
with any cellular vesicle.
f.
Many viruses have evolved mechanisms to subvert various arms of the
immune system, ranging from capturing cellular genes for cytokines to
synthesizing complement regulatory molecules or inhibiting MHC class I synthesis
or assembly.
5.
Immunosuppression
a.
Many pathogens suppress immune responses in general.
b.
For example, staphylococcal bacteria produce toxins, such as the
staphylococcal enterotoxins and toxic shock syndrome toxin-1, that act as
superantigens.
c.
Superantigens are proteins that bind the antigen receptor of very large
numbers of T cells, stimulating them to produce cytokines that cause significant
suppression of all immune responses.
d.
The stimulated T cells proliferate and then rapidly undergo apoptosis,
leaving a generalized suppression with peripheral deletion of many T cells.
6.
Mechanisms of subversion of host immune system
|
Viral
strategy |
Specific
mechanism |
Result |
Virus
examples |
|
Inhibition
of humoral immunity |
Virally
encoded Fc receptor |
Blocks
effector functions of antibodies bound to infected cells |
Herpes
simplex Cytomegalovirus |
|
Virally
encoded complement receptor |
Blocks
complement-mediated effector pathways |
Herpes
simplex |
|
|
Virally
encoded complement control protein |
Inhibits
complement activation of infected cell |
Vaccinia |
|
|
Inhibition
of inflammatory response |
Virally
encoded soluble cytokine receptor, e.g. IL-1 |
Blocks
effects of cytokines by inhibiting their interaction with host receptors |
Vaccinia |
|
Viral
inhibition of adhesion molecule expression, e.g. ICAM-1 |
Blocks
adhesion of lymphocytes to infected cells. |
Epstein-Barr
virus |
|
|
Blocking
of antigen processing and presentation |
Inhibition
of MHC-class I expression |
Impairs
recognition of infected cells by cytotoxic T cells |
Herpes
simplex Cytomegalovirus |
|
Inhibition
of peptide transport by TAP |
Blocks
peptide association with class I MHC |
Herpes
simplex |
|
|
Immunosuppression
of host cells |
Virally
encoded cytokine IL-10 |
Inhibits
TH1 cells Reduces
gamma interferone production |
Epstein-Barr
virus |